Related references
Note: Only part of the references are listed.Homogeneous time-resolved fluorescence-based assay to screen for ligands targeting the growth hormone secretagogue receptor type 1a
Jean-Philippe Leyris et al.
ANALYTICAL BIOCHEMISTRY (2011)
Pancreatic cancers require autophagy for tumor growth
Shenghong Yang et al.
GENES & DEVELOPMENT (2011)
Importance of Receptor Flexibility in Binding of Cyclam Compounds to the Chemokine Receptor CXCR4
Alfonso R. Lam et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2011)
Therapeutic potential of β-arrestin- and G protein-biased agonists
Erin J. Whalen et al.
TRENDS IN MOLECULAR MEDICINE (2011)
HIV-1 Entry Cofactor: Functional cDNA Cloing of a Seven-Transmembrane, G protein-Coupled Receptor
Yu Feng et al.
JOURNAL OF IMMUNOLOGY (2011)
Chloroquine potentiates the anti-cancer effect of 5-fluorouracil on colon cancer cells
Kazuhito Sasaki et al.
BMC CANCER (2010)
CXCL12-CXCR4 signalling axis confers gemcitabine resistance to pancreatic cancer cells: a novel target for therapy
S. Singh et al.
BRITISH JOURNAL OF CANCER (2010)
A Genome-Wide siRNA Screen Reveals Multiple mTORC1 Independent Signaling Pathways Regulating Autophagy under Normal Nutritional Conditions
Marta M. Lipinski et al.
DEVELOPMENTAL CELL (2010)
The Peptidomimetic CXCR4 Antagonist TC14012 Recruits β-Arrestin to CXCR7 ROLES OF RECEPTOR DOMAINS
Stephanie Gravel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Computational Mapping of the Conformational Transitions in Agonist Selective Pathways of a G-Protein Coupled Receptor
Supriyo Bhattacharya et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2010)
Metastatic pancreatic cancer: Is gemcitabine still the best standard treatment? (Review)
Mariacristina Di Marco et al.
ONCOLOGY REPORTS (2010)
Chemokine Receptor CXCR4 Enhances Proliferation in Pancreatic Cancer Cells Through AKT and ERK Dependent Pathways
Xiaoming Shen et al.
PANCREAS (2010)
Structures of the CXCR4 Chemokine GPCR with Small-Molecule and Cyclic Peptide Antagonists
Beili Wu et al.
SCIENCE (2010)
A Fluorescent Ligand-Binding Alternative Using Tag-lite (R) Technology
Jurriaan M. Zwier et al.
JOURNAL OF BIOMOLECULAR SCREENING (2010)
AMD3100 Is a CXCR7 Ligand with Allosteric Agonist Properties
Irina Kalatskaya et al.
MOLECULAR PHARMACOLOGY (2009)
Impaired Recruitment of Grk6 and β-Arrestin2 Causes Delayed Internalization and Desensitization of a WHIM Syndrome-Associated CXCR4 Mutant Receptor
Peter J. McCormick et al.
PLOS ONE (2009)
A Homogeneous Fluorescent Live-Cell Assay for Measuring 7-Transmembrane Receptor Activity and Agonist Functional Selectivity Through Beta-Arrestin Recruitment
Bonnie J. Hanson et al.
JOURNAL OF BIOMOLECULAR SCREENING (2009)
Kappa Opioid Receptor Screen with the Tango™ β-Arrestin Recruitment Technology and Characterization of Hits with Second-Messenger Assays
Christopher Doucette et al.
JOURNAL OF BIOMOLECULAR SCREENING (2009)
HIV-1 gp41 fusogenic function triggers autophagy in uninfected cells
Melanie Denizot et al.
AUTOPHAGY (2008)
Targeting lysosomal degradation induces p53-dependent cell death and prevents cancer in mouse models of lymphomagenesis
Kirsteen H. Maclean et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Comparison of the Potential Multiple Binding Modes of Bicyclam, Monocylam, and Noncyclam Small-Molecule CXC Chemokine Receptor 4 Inhibitors
Rebecca S. Y. Wong et al.
MOLECULAR PHARMACOLOGY (2008)
Crystal structure of the ligand-free G-protein-coupled receptor opsin
Jung Hee Park et al.
NATURE (2008)
Molecular mechanism of action of Monocyclam versus Bicyclam non-peptide antagonists in the CXCR4 chemokine receptor
Mette M. Rosenkilde et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Prediction of the 3D structure of FMRF-amide neuropeptides bound to the mouse MrgC11 GPCR and experimental validation
Jiyoung Heo et al.
CHEMBIOCHEM (2007)
Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: A phase III trial of the National Cancer Institute of Canada clinical trials group
Malcolm J. Moore et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Hemozoin biocrystallization in Plasmodium falciparum and the antimalarial activity of crystallization inhibitors
Ernst Hempelmann
PARASITOLOGY RESEARCH (2007)
The pleiotropic effects of the SDF-1-CXCR4 axis in organogenesis, regeneration and tumorigenesis
M. Z. Ratajczak et al.
LEUKEMIA (2006)
Chemokine receptor CXCR4 expression in patients with melanoma and colorectal cancer liver metastases and the association with disease outcome
Joseph Kim et al.
ANNALS OF SURGERY (2006)
Adding chloroquine to conventional treatment for glioblastoma multiforme -: A randomized, double-blind, placebo-controlled trial
J Sotelo et al.
ANNALS OF INTERNAL MEDICINE (2006)
CXCR4 expression increases liver and lung metastasis in a mouse model of pancreatic cancer
D Saur et al.
GASTROENTEROLOGY (2005)
Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival
J Kim et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Potential clinical applications of the CXCR4 antagonist bicyclam AMD3100
E De Clercq
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2005)
First principles predictions of the structure and function of G-protein-coupled receptors: Validation for bovine rhodopsin
RJ Trabanino et al.
BIOPHYSICAL JOURNAL (2004)
Safety, pharmacokinetics, and antiviral activity of AMD3100, a selective CXCR4 receptor inhibitor, in HIV-1 infection
CW Hendrix et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2004)
Increased survival, proliferation, and migration in metastatic human pancreatic tumor cells expressing functional CXCR4
F Marchesi et al.
CANCER RESEARCH (2004)
Structure of bovine rhodopsin in a trigonal crystal form
J Li et al.
JOURNAL OF MOLECULAR BIOLOGY (2004)
A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors
JB Rubin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Hydroxychloroquine is much less active than chloroquine against chloroquine-resistant Plasmodium falciparum, in agreement with its physicochemical properties
DC Warhurst et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
Chemokine receptor inhibition by AMD3100 is strictly confined to CXCR4
S Hatse et al.
FEBS LETTERS (2002)
Functional selectivity of dopamine receptor agonists.: II.: Actions of dihydrexidine in D2L receptor-transfected MN9D cells and pituitary lactotrophs
JD Kilts et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Enhanced CACTVS browser of the open NCI database
WD Ihlenfeldt et al.
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES (2002)
Share Paper
